US Stock MarketDetailed Quotes

ZIVO Zivo Bioscience

Watchlist
  • 8.452
  • 0.0000.00%
15min DelayClose Jul 24 11:02 ET
27.71MMarket Cap-2218P/E (TTM)

Zivo Bioscience Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
35.72K
27.65K
11.8K
11.8K
4.05K
0
0
0
0
0
Operating revenue
--35.72K
--27.65K
--11.8K
--11.8K
--4.05K
--0
--0
--0
--0
--0
Cost of revenue
23.22K
16.04K
7.67K
7.67K
701
0
0
0
0
0
Gross profit
12.5K
11.61K
4.13K
4.13K
3.35K
0
0
0
0
0
Operating expense
-34.61%1.29M
-16.69%7.27M
-27.94%1.9M
-21.18%1.58M
-11.63%1.83M
-2.78%1.97M
1.00%8.73M
-19.20%2.64M
19.54%2M
18.19%2.07M
Selling and administrative expenses
-37.80%975.57K
-9.15%5.9M
-25.03%1.59M
-2.94%1.36M
-15.00%1.39M
16.46%1.57M
-3.03%6.49M
-22.25%2.12M
10.51%1.4M
27.16%1.63M
-General and administrative expense
-37.80%975.57K
-9.15%5.9M
-25.03%1.59M
-2.94%1.36M
-15.00%1.39M
16.46%1.57M
-3.03%6.49M
-22.25%2.12M
10.51%1.4M
27.16%1.63M
Research and development costs
-22.16%312.77K
-38.53%1.38M
-39.83%312.47K
-63.41%220.65K
0.93%442.11K
-40.89%401.8K
14.86%2.24M
-3.81%519.35K
47.45%603.11K
-6.38%438.05K
Operating profit
35.24%-1.28M
16.82%-7.26M
28.10%-1.9M
21.38%-1.57M
11.79%-1.82M
2.78%-1.97M
-1.00%-8.73M
19.20%-2.64M
-19.54%-2M
-18.19%-2.07M
Net non-operating interest income expense
10.78%-2.65K
-3,760.44%-514.17K
-294.66%-11.96K
-5,848.98%-252.53K
-5,721.28%-246.71K
-64.43%-2.97K
94.29%-13.32K
-112.55%-3.03K
-1,931.10%-4.25K
95.60%-4.24K
Non-operating interest expense
-10.78%2.65K
3,760.44%514.17K
294.66%11.96K
5,848.98%252.53K
5,721.28%246.71K
64.43%2.97K
-94.29%13.32K
112.55%3.03K
1,931.10%4.25K
-95.60%4.24K
Other net income (expense)
Income before tax
35.21%-1.28M
11.07%-7.78M
27.73%-1.91M
8.95%-1.82M
0.06%-2.07M
2.72%-1.97M
0.12%-8.75M
19.12%-2.64M
-29.18%-2M
-12.26%-2.07M
Income tax
Net income
35.21%-1.28M
11.07%-7.78M
27.73%-1.91M
8.95%-1.82M
0.06%-2.07M
2.72%-1.97M
0.12%-8.75M
19.12%-2.64M
-29.18%-2M
-12.26%-2.07M
Net income continuous Operations
35.21%-1.28M
11.07%-7.78M
27.73%-1.91M
8.95%-1.82M
0.06%-2.07M
2.72%-1.97M
0.12%-8.75M
19.12%-2.64M
-29.18%-2M
-12.26%-2.07M
Minority interest income
Net income attributable to the parent company
35.21%-1.28M
11.07%-7.78M
27.73%-1.91M
8.95%-1.82M
0.06%-2.07M
2.72%-1.97M
0.12%-8.75M
19.12%-2.64M
-29.18%-2M
-12.26%-2.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.21%-1.28M
11.07%-7.78M
27.73%-1.91M
8.95%-1.82M
0.06%-2.07M
2.72%-1.97M
0.12%-8.75M
19.12%-2.64M
-29.18%-2M
-12.26%-2.07M
Basic earnings per share
62.70%-0.47
17.41%-4.6
42.86%-0.96
17.97%-1.05
0.00%-1.32
4.55%-1.26
19.28%-5.57
19.22%-1.68
11.11%-1.28
21.43%-1.32
Diluted earnings per share
62.70%-0.47
17.41%-4.6
42.86%-0.96
17.97%-1.05
0.00%-1.32
4.55%-1.26
19.28%-5.57
19.22%-1.68
11.11%-1.28
21.43%-1.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 35.72K27.65K11.8K11.8K4.05K00000
Operating revenue --35.72K--27.65K--11.8K--11.8K--4.05K--0--0--0--0--0
Cost of revenue 23.22K16.04K7.67K7.67K70100000
Gross profit 12.5K11.61K4.13K4.13K3.35K00000
Operating expense -34.61%1.29M-16.69%7.27M-27.94%1.9M-21.18%1.58M-11.63%1.83M-2.78%1.97M1.00%8.73M-19.20%2.64M19.54%2M18.19%2.07M
Selling and administrative expenses -37.80%975.57K-9.15%5.9M-25.03%1.59M-2.94%1.36M-15.00%1.39M16.46%1.57M-3.03%6.49M-22.25%2.12M10.51%1.4M27.16%1.63M
-General and administrative expense -37.80%975.57K-9.15%5.9M-25.03%1.59M-2.94%1.36M-15.00%1.39M16.46%1.57M-3.03%6.49M-22.25%2.12M10.51%1.4M27.16%1.63M
Research and development costs -22.16%312.77K-38.53%1.38M-39.83%312.47K-63.41%220.65K0.93%442.11K-40.89%401.8K14.86%2.24M-3.81%519.35K47.45%603.11K-6.38%438.05K
Operating profit 35.24%-1.28M16.82%-7.26M28.10%-1.9M21.38%-1.57M11.79%-1.82M2.78%-1.97M-1.00%-8.73M19.20%-2.64M-19.54%-2M-18.19%-2.07M
Net non-operating interest income expense 10.78%-2.65K-3,760.44%-514.17K-294.66%-11.96K-5,848.98%-252.53K-5,721.28%-246.71K-64.43%-2.97K94.29%-13.32K-112.55%-3.03K-1,931.10%-4.25K95.60%-4.24K
Non-operating interest expense -10.78%2.65K3,760.44%514.17K294.66%11.96K5,848.98%252.53K5,721.28%246.71K64.43%2.97K-94.29%13.32K112.55%3.03K1,931.10%4.25K-95.60%4.24K
Other net income (expense)
Income before tax 35.21%-1.28M11.07%-7.78M27.73%-1.91M8.95%-1.82M0.06%-2.07M2.72%-1.97M0.12%-8.75M19.12%-2.64M-29.18%-2M-12.26%-2.07M
Income tax
Net income 35.21%-1.28M11.07%-7.78M27.73%-1.91M8.95%-1.82M0.06%-2.07M2.72%-1.97M0.12%-8.75M19.12%-2.64M-29.18%-2M-12.26%-2.07M
Net income continuous Operations 35.21%-1.28M11.07%-7.78M27.73%-1.91M8.95%-1.82M0.06%-2.07M2.72%-1.97M0.12%-8.75M19.12%-2.64M-29.18%-2M-12.26%-2.07M
Minority interest income
Net income attributable to the parent company 35.21%-1.28M11.07%-7.78M27.73%-1.91M8.95%-1.82M0.06%-2.07M2.72%-1.97M0.12%-8.75M19.12%-2.64M-29.18%-2M-12.26%-2.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.21%-1.28M11.07%-7.78M27.73%-1.91M8.95%-1.82M0.06%-2.07M2.72%-1.97M0.12%-8.75M19.12%-2.64M-29.18%-2M-12.26%-2.07M
Basic earnings per share 62.70%-0.4717.41%-4.642.86%-0.9617.97%-1.050.00%-1.324.55%-1.2619.28%-5.5719.22%-1.6811.11%-1.2821.43%-1.32
Diluted earnings per share 62.70%-0.4717.41%-4.642.86%-0.9617.97%-1.050.00%-1.324.55%-1.2619.28%-5.5719.22%-1.6811.11%-1.2821.43%-1.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg